The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.
Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine as concerns about a bird flu pandemic in humans ...
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect against bird flu, the pharmaceutical company announced Friday.
The U.S. has reported its first death due to bird flu, aka H5N1. How deadly is H5N1? Experts discuss bird flu fatality rate amid ongoing outbreak.